# FDA recall D-0040-2024

> **Imprimis NJOF, LLC** · Class III · drug recall initiated 2023-10-03.

## Product

Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01  Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023  Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979

## Reason for recall

Subpotent: Failing Test Results for Epinephrine

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0040-2024
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-10-03
- **Report date:** 2023-10-11
- **Termination date:** 2025-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0040-2024

## Citation

> AI Analytics. FDA recall D-0040-2024. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0040-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*